Skip to Content

Generic vs Branded Medicines: What International Buyers Need to Know


When sourcing pharmaceuticals from India, one of the first decisions importers face is whether to buy generic or branded medicines. Both are legitimate, widely used options  but understanding the difference helps buyers make informed choices for their market, budget, and regulatory environment.

What Is a Branded Medicine?

A branded medicine is developed and marketed by the company that originally researched and patented the drug. The price reflects years of research, clinical trials, and marketing investment. Branded medicines are typically the first version of a drug to enter the market, sold under a proprietary trade name.

What Is a Generic Medicine?

A generic medicine contains the same active pharmaceutical ingredient (API), strength, dosage form, and route of administration as its branded counterpart. It becomes available once the original drug's patent expires. Generics undergo strict bioequivalence testing to confirm they perform the same way in the body as the branded version, but they cost significantly less because manufacturers don't bear the original research and development expense.

Why India Is a Leading Generic Medicine Exporter

India supplies a significant share of the world's generic medicines, particularly to markets in Africa, Southeast Asia, Latin America, and the Middle East. This is driven by:

  • Cost-efficient manufacturing without compromising on active ingredient quality
  • WHO-GMP and international certifications held by major Indian manufacturers
  • Large-scale production capacity to meet bulk export demand
  • A mature pharmaceutical ecosystem with experienced formulation and quality control expertise


Which Should You Import: Generic or Branded?

The right choice depends on a few factors:

  • Regulatory requirements in your country — some markets mandate specific registration pathways for generics vs originator brands
  • End-market pricing sensitivity — generics offer significant cost advantages for public health programs and price-sensitive markets
  • Therapeutic category — for certain critical or narrow-therapeutic-index drugs, buyers may prefer specific manufacturers regardless of brand status
  • Supplier track record — regardless of generic or branded status, the manufacturer's certifications, batch testing, and export history matter most

What to Verify Before Importing Either Type

  1. WHO-GMP, EU-GMP, or relevant certification for the target market
  2. Valid drug manufacturing and export licenses
  3. Batch-wise Certificate of Analysis (CoA)
  4. Stability data suited to your climate zone
  5. Registration status or dossier availability for your country



Generic and branded medicines are both effective and regulated options  the difference lies in cost, manufacturer, and market positioning, not in therapeutic quality when sourced from a certified supplier. For international buyers, the priority should always be verifying the supplier's certifications and quality systems rather than the brand label alone